Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Charles River Laboratories Intl (CRL)

Charles River Laboratories Intl (CRL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,292,088
  • Shares Outstanding, K 50,253
  • Annual Sales, $ 2,924 M
  • Annual Income, $ 364,300 K
  • 60-Month Beta 1.14
  • Price/Sales 6.20
  • Price/Cash Flow 27.77
  • Price/Book 8.12
Trade CRL with:

Options Overview

Details
  • Implied Volatility 26.07%
  • Historical Volatility 19.26%
  • IV Percentile 2%
  • IV Rank 5.24%
  • IV High 48.90% on 10/28/20
  • IV Low 24.81% on 05/28/21
  • Put/Call Vol Ratio 0.07
  • Today's Volume 327
  • Volume Avg (30-Day) 219
  • Put/Call OI Ratio 1.27
  • Today's Open Interest 4,300
  • Open Int (30-Day) 4,873

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 2.35
  • Number of Estimates 8
  • High Estimate 2.49
  • Low Estimate 2.03
  • Prior Year 1.58
  • Growth Rate Est. (year over year) +48.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
323.07 +13.58%
on 05/26/21
368.14 -0.32%
on 06/23/21
+39.72 (+12.14%)
since 05/21/21
3-Month
273.52 +34.16%
on 03/25/21
368.14 -0.32%
on 06/23/21
+86.64 (+30.91%)
since 03/23/21
52-Week
165.76 +121.37%
on 06/24/20
368.14 -0.32%
on 06/23/21
+191.94 (+109.67%)
since 06/23/20

Most Recent Stories

More News
What Makes Charles River Laboratories (CRL) a Strong Momentum Stock: Buy Now?

Does Charles River Laboratories (CRL) have what it takes to be a top stock pick for momentum investors? Let's find out.

CRL : 366.95 (+0.81%)
Microbiology Diagnostic Devices And Equipment Global Market Report 2021: COVID-19 Implications And Growth To 2030

Reportlinker.com announces the release of the report "Microbiology Diagnostic Devices And Equipment Global Market Report 2021: COVID-19 Implications And Growth To 2030" - https://www.reportlinker.com/p06097016/?utm_source=GNW...

CRL : 366.95 (+0.81%)
HOLX : 64.47 (+0.70%)
MKKGY : 37.1350 (-1.06%)
NEOG : 45.29 (-0.96%)
SARTF : 474.0000 (-0.21%)
TSIA : 10.83 (-0.09%)
PCPAF : 0.0100 (unch)
Proactive news headlines including Comet Resources, Poseidon Nickel, Calima Energy and Piedmont Lithium

Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

AGC : 11.71 (+0.34%)
CRL : 366.95 (+0.81%)
IPGDF : 5.8200 (+3.19%)
PSDNF : 0.0700 (unch)
GBR : 5.82 (-1.19%)
PLL : 74.11 (+7.14%)
PDDTF : 0.6000 (+1.68%)
BRK : 193.01 (-0.41%)
CHN : 29.37 (+1.27%)
CGMLF : 5.5000 (+4.86%)
Duke Energy (DUK) Brand Starts Building 250MW Solar Project

Duke Energy (DUK) announces the 250-MW Pisgah Ridge Solar project will supply power to three corporations, once its construction is completed by 2022-end.

CMS : 58.54 (-0.12%)
D : 74.55 (-1.45%)
CRL : 366.95 (+0.81%)
DUK : 99.23 (-1.17%)
Duke Energy Sustainable Solutions will build its largest solar project to date: 250-MW Pisgah Ridge Solar in Texas

/PRNewswire/ -- Duke Energy Sustainable Solutions*, a nonregulated commercial brand of Duke Energy (NYSE: DUK), today announced the start of construction of the 250-megawatt (MW) Pisgah Ridge Solar project...

CRL : 366.95 (+0.81%)
DUK : 99.23 (-1.17%)
Charles River Laboratories Announces Long-Term Solar Contract for North American Operations

Charles River Laboratories International, Inc. (NYSE: CRL) today announced a long-term solar energy contract to address the entirety of the Company's North American electric power requirements with clean,...

CRL : 366.95 (+0.81%)
DUK : 99.23 (-1.17%)
Charles River Laboratories to Participate in June Investor Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at three upcoming investor conferences, including:

CRL : 366.95 (+0.81%)
Charles River Laboratories to Host Virtual Investor Day

Charles River Laboratories International, Inc. (NYSE: CRL) announced that it will host a virtual Meeting with Management on Thursday, May 27th, beginning at 8:30 a.m. ET.

CRL : 366.95 (+0.81%)
Clinical Laboratory Tests Market Size to Reach USD 327.4 Billion in 2028: Rising prevalence of chronic diseases and increasing need for advanced diagnostic techniques to drive market growth, Says Reports and Data

Market Size - USD 189.8 billion in 2020, Market Growth - at a CAGR of 7.3%, Market Trends - Rising focus of health-conscious people on regular body profiling

ABT : 110.84 (-0.11%)
CRL : 366.95 (+0.81%)
ERRFY : 11.9900 (+19.90%)
OPK : 3.70 (-3.65%)
DGX : 129.16 (-0.83%)
SIEGY : 81.6400 (-0.02%)
SKHCF : 28.2000 (-1.05%)
Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has signed a definitive agreement to acquire Vigene Biosciences, Inc., a premier, U.S.-based gene therapy contract development...

CRL : 366.95 (+0.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Their dedicated employees are focused...

See More

Key Turning Points

3rd Resistance Point 373.83
2nd Resistance Point 370.98
1st Resistance Point 368.97
Last Price 366.95
1st Support Level 364.11
2nd Support Level 361.26
3rd Support Level 359.25

See More

52-Week High 368.14
Last Price 366.95
Fibonacci 61.8% 290.83
Fibonacci 50% 266.95
Fibonacci 38.2% 243.07
52-Week Low 165.76

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar